Intervention

Placebo SC

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 7 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials7
Recruiting1
Common conditions11
Lead sponsors shown6
Advertisement

Clinical trials

7 shown
A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 DiabetesNCT06945406 · 2025-05-16
RECRUITING
A Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection)NCT06048120 · 2023-09-15
COMPLETED
A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)NCT02614131 · 2015-12-01
TERMINATED
A Pilot Clinical Trial of Exendin-4 in Alzheimer's DiseaseNCT01255163 · 2010-11-21
TERMINATED
The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and PrediabetesNCT01181986 · 2010-08-01
COMPLETED
Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)NCT01004432 · 2009-12-01
COMPLETED
To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using MethotrexateNCT01009242 · 2009-10-01
COMPLETED

Trial status mix

COMPLETED4
TERMINATED2
RECRUITING1

Phase mix

PHASE14
PHASE22
PHASE31
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.